Science Explorer Interactive view Map
Company · Burlington · Canada

Evonik (Canada)

corporate.evonik.com/enROR OpenAlex
Research works
2
fractional, all time
Citations
107
54.9 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
52%
world 28%

Not ranked overall: Evonik (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Evonik (Canada) publish most on?

By volume in 2022–2025: Cell death mechanisms and regulation, Protein Degradation and Inhibitors and Autophagy in Disease and Therapy.

Cell death mechanisms an…0Cell death mechanisms and regulation: 0 fractional worksProtein Degradation and …0Protein Degradation and Inhibitors: 0 fractional worksAutophagy in Disease and…0Autophagy in Disease and Therapy: 0 fractional works
Molecular BiologyEpidemiology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cell death mechanisms and regulation Molecular Biology 0 works
  2. 2 Protein Degradation and Inhibitors Molecular Biology 0 works
  3. 3 Autophagy in Disease and Therapy Epidemiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.8%not open48.2%

World: 28% of research is openly available.

with international co-authors31.7%domestic only68.3%

World: 19% is written across borders.

How has Evonik (Canada)'s research output changed?

201020152020

Other research institutions in Burlington

All research institutions in Burlington

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.